News

IBSA Iron ODF is part of a new range of oral film supplements now available from IBSA Care. The range also includes IBSA Vitamin D3 ODF, a 2000 IU supplement formulated to support bone and immune ...
“We are thrilled to be growing in Iowa again, after our successful additions last year” said Barry Port, Ensign's Chief Executive Officer. “We had another perfect opportunity to add to Standard Bearer ...
“This is a perfect addition to our growing portfolio in the great state of Wisconsin. This new addition joins our existing operations and allows us to offer even more services to the communities in ...
The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech ...
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical ...
Leiden, the Netherlands, August 4, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor ...
Paris, France (4 August 2025) – EssilorLuxottica announces today the acquisition of Automation & Robotics (A&R), a renowned player in the design and manufacture of automated systems for optical lens ...
(“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final Rule (IPPS) for ...
The shares of common stock were offered by Prime Medicine pursuant to an effective shelf registration statement on Form S-3 that was previously filed with the U.S. Securities and Exchange Commission ...
Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non‑dilutive ...
We encourage physicians in the northeastern United States to seize this opportunity to offer the SVDx test to their patients. By identifying vascular risks earlier, healthcare providers can implement ...
Over the past few days, shares of Pheton have experienced an extraordinary and unexpected decline in its share price, which the Company believes may have been triggered by a speculative article ...